EUVIMEDEUVIMED entdecken
Crossref

Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder

Cheng-Jhe Wu, Jin-Jia Lin, Chih-Chun Huang, Huai-Hsuan Tseng, Wan-Lin Cheng, Chi-Yu Yao, Tzu-Yun Wang, Po-See Chen, Chi-Wei Chiu, Chih-Wei Lin, Yu-En Kang, Kuang-Yu Hsieh und 1 weitere

Schizophrenia Research · 2026-07 · 293 · 113-123

DOI: 10.1016/j.schres.2026.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research, 2026-07. Verfasst von Cheng-Jhe Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Bipolar Disorder, Schizophrenia, Niacin, Flushing. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Taiwan Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our previous study demonstrated that the niacin flush response and pathway biomarkers could differentiate schizophrenia patients from healthy controls. Whether these biomarkers also distinguish schizophrenia from bipolar disorder remains unclear. This study aimed to develop and validate predictive models to differentiate schizophrenia, bipolar disorder, and healthy controls. Independent training and validation sets were established for schizophrenia and healthy controls, and model performance was further evaluated in distinguishing schizophrenia from bipolar disorder. We recruited 223 schizophrenia patients, 62 bipolar disorder patients, and 162 healthy controls in Taiwan. Logistic regression was used to construct prediction models. The prediction model demonstrated high discriminative performance in differentiating individuals with schizophrenia from healthy controls, achieving an AUC of 0.97 in the training set and 0.92 in the validation set. Furthermore, the model effectively distinguished schizophrenia from bipolar disorder, with an AUC of 0.96, and 0.91 for cross-validated results. Niacin flush response and GPR109A were the most significant for differentiating schizophrenia patients from healthy controls, while EP2, PGE2, and GPR109A were key for schizophrenia and bipolar disorder classification. Principal component and partial least squares-discriminant analyses confirmed separation among different groups. Shapley Additive Explanation value analysis demonstrated divergent feature importance of biomarkers, indicating differential regulation of the niacin flush pathway in schizophrenia and bipolar patients. We externally validated that biomarkers from the niacin flush pathway were good candidates for distinguishing schizophrenia patients from healthy controls, while EP2, PGE2, and GPR109A may further aid in differentiating schizophrenia from bipolar disorder, potentially reflecting their distinct etiological underpinnings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderSchizophreniaNiacinFlushingHumansFemaleAdultBiomarkersMaleDiagnosis, DifferentialReceptors, G-Protein-CoupledReceptors, NicotinicMiddle AgedYoung Adult

Stichwörter der Autor:innen

Bipolar disorderDiscriminant analysisNiacin flush pathwayPrediction modelSchizophrenia

Substanzen

NiacinBiomarkersReceptors, G-Protein-CoupledHCAR2 protein, humanReceptors, NicotinicHCAR3 protein, human

Autor:innen und Institutionen

  • Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan; Department of Psychiatry, Yo-Chin Foundation Yo-Chin Hospital, Pingtung, Taiwan.
  • Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Psychiatry, National Cheng Kung University Hospital, Dou-Liou Branch,…
  • Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Institute of Behavioral Medicine, College of Medicine, National Cheng Kung Universi…
  • Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Psychiatry, Tainan Municipal An-Nan Hospital, Tainan, Taiwan.

Förderung

  • Ministry of Science and Technology, Taiwan
  • Taiwan Ministry of Science and Technology

Zitieren

APA

Wu, C. J., Lin, J. J., Huang, C. C., Tseng, H. H., Cheng, W. L., Yao, C. Y., Wang, T. Y., Chen, P. S., Chiu, C. W., Lin, C. W., Kang, Y. E., Hsieh, K. Y., & Lin, S. H. (2026). Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder. Schizophrenia Research, 293, 113-123. https://doi.org/10.1016/j.schres.2026.04.002

Vancouver

Wu CJ, Lin JJ, Huang CC, Tseng HH, Cheng WL, Yao CY, et al. Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder. Schizophrenia Research. 2026;293:113-123. doi:10.1016/j.schres.2026.04.002

BibTeX
@article{Wu2026,
  author = {Wu, Cheng-Jhe and Lin, Jin-Jia and Huang, Chih-Chun and Tseng, Huai-Hsuan and Cheng, Wan-Lin and Yao, Chi-Yu and Wang, Tzu-Yun and Chen, Po-See and Chiu, Chi-Wei and Lin, Chih-Wei and Kang, Yu-En and Hsieh, Kuang-Yu and Lin, Sheng-Hsiang},
  title = {Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder},
  journal = {Schizophrenia Research},
  year = {2026},
  volume = {293},
  pages = {113--123},
  doi = {10.1016/j.schres.2026.04.002}
}
Kostenlos starten →